BR0209403A - Modified fvii use, and, method for treating acute lung injury or acute respiratory disease syndrome in humans. - Google Patents

Modified fvii use, and, method for treating acute lung injury or acute respiratory disease syndrome in humans.

Info

Publication number
BR0209403A
BR0209403A BR0209403-7A BR0209403A BR0209403A BR 0209403 A BR0209403 A BR 0209403A BR 0209403 A BR0209403 A BR 0209403A BR 0209403 A BR0209403 A BR 0209403A
Authority
BR
Brazil
Prior art keywords
humans
respiratory disease
acute
modified fvii
lung injury
Prior art date
Application number
BR0209403-7A
Other languages
Portuguese (pt)
Inventor
Mirella Ezban
Steven Idell
Claude A Piantados
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority claimed from PCT/DK2002/000279 external-priority patent/WO2002087605A2/en
Publication of BR0209403A publication Critical patent/BR0209403A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE FVII MODIFICADO, E, MéTODO PARA TRATAR O DANO PULMONAR AGUDO OU A SìNDROME DA DOENçA RESPIRATóRIA AGUDA EM SERES HUMANOS". A presente invenção diz respeito ao uso do fator VII modificado para a fabricação de medicamentos para o tratamento do dano pulmonar agudo (ALI) ou da síndrome da angústia respiratória aguda (ARDS) em seres humanos."USE OF MODIFIED FVII, AND METHOD TO TREAT ACUTE LUNG DAMAGE OR ACUTE RESPIRATORY DISEASE SYNDROME IN HUMANS". The present invention relates to the use of modified factor VII for the manufacture of medicaments for the treatment of acute pulmonary injury (ALI) or acute respiratory distress syndrome (ARDS) in humans.

BR0209403-7A 2001-05-02 2002-05-01 Modified fvii use, and, method for treating acute lung injury or acute respiratory disease syndrome in humans. BR0209403A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100069 2001-05-02
PCT/DK2002/000279 WO2002087605A2 (en) 2001-05-02 2002-05-01 Modified fvii in treatment of ards

Publications (1)

Publication Number Publication Date
BR0209403A true BR0209403A (en) 2004-07-06

Family

ID=32523918

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209403-7A BR0209403A (en) 2001-05-02 2002-05-01 Modified fvii use, and, method for treating acute lung injury or acute respiratory disease syndrome in humans.

Country Status (1)

Country Link
BR (1) BR0209403A (en)

Similar Documents

Publication Publication Date Title
WO2001093846A3 (en) Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans
ATE427129T1 (en) DISPENSING DEVICE FOR MEDICINAL PRODUCTS
WO2002047668A3 (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
EE05311B1 (en) A process for treating a mineral "active ingredient" with polysiloxane and fatty acid to produce h drophobic active ingredients and their use in polymerization for "breathable" films
NO20072906L (en) Method of preventing or treating respiratory infections and acute otitis media in children
EE200300514A (en) Phthalazinones, their use in the manufacture of medicaments for the treatment of respiratory symptoms and medicinal products containing them
BR0213540A (en) Compounds, method for treating a patient's illness or disorder and a pharmaceutical composition comprising them
BR0307291A (en) Compound; process for the preparation of a compound; pharmaceutical composition; use of a compound; method for the treatment and prophylaxis of various disorders and obesity in a human
ES2096577T3 (en) USE OF CETOCONAZOLE AND A RETINOID FOR THE TREATMENT OF VULGAR ACNE.
ATE427114T1 (en) USE OF HEPCIDIN FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF IRON HOMEOSTASIS DISORDERS
DK1411932T3 (en) Combination therapy with substituted oxazolidinones
BRPI0414425A (en) pharmaceutical compositions
BRPI0510084A (en) benzoxazine for treatment of respiratory tract diseases
BRPI0313792B8 (en) use of erythropoietin protein, method for treating iron distribution disorders in diabetes and medication for its treatment
DK0942741T3 (en) Lectin preparations and uses thereof
BR0310061A (en) Methods for treating respiratory diseases and conditions with a selective inhibitor of inos and a inhibitor of pde and their compositions
WO2005051331A3 (en) Chaperone-based therapy for niemann-pick disease
WO2002087605A3 (en) Modified fvii in treatment of ards
BR0209403A (en) Modified fvii use, and, method for treating acute lung injury or acute respiratory disease syndrome in humans.
DE69918961D1 (en) IMPROVED INHALATION PRODUCTS
BR0213479A (en) Use of irbesartan for the preparation of medicinal products useful for the prevention or treatment of pulmonary hypertension.
CO5690571A2 (en) SYNERGIC COMBINATION INCLUDING ROFLUMILAS AND (R, R) -FORMOTEROL
DE60206280D1 (en) USE OF EXTRACTS FROM GINKGO BILOBA FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SARCOPENIA
BR0313665A (en) Bupropion for the treatment of restless leg syndrome
BR0011049A (en) Substituted phenylcyclohexanocarboxamides and their use as adenosine absorption inhibitors

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired